Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression

International Clinical Psychopharmacology

Volumn 25, Issue 2, 2010, Pages 68-74

  Benvenuti, Antonella ^a   Rucci, Paola ^b,c   Calugi, Simona ^a   Cassano, Giovanni B ^a   Miniati, Mario ^a   Frank, Ellen ^c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Depression; Functioning; Quality of life; Remission; Residual; Unipolar

Indexed keywords

ADULT; AGORAPHOBIA; ARTICLE; DISEASE SEVERITY; FEAR; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD; MOOD AND PANIC AGORAPHOBIC SPECTRUM QUESTIONNAIRE; MOOD SPECTRIM SELF REPORT QUESTIONNAIRE; MOOD SPECTRUM SELF REPORT QUESTIONNAIRE; OUTPATIENT; PANIC; PANIC AGORAPHOBIC SPECTRUM SPECTRUM SELF REPORT QUESTIONNAIRE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; PSYCHOSIS; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; QUESTIONNAIRE; REMISSION; SEPARATION ANXIETY; SYMPTOM; SYMPTOMATOLOGY; WORK AND SOCIAL ADJUSTMENT SCALE;

ADULT; AFFECT; AGORAPHOBIA; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REGRESSION ANALYSIS;

EID: 76349096878     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328333ee8e     Document Type: Article

References (56)

1. Akiskal HS, Benazzi F (2006). The DSM-IV and ICD-10 categories of recurrent (major) depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum. J Affect Disord 92:45-54.
2. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R (2000). Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 59:S5-S30.
3. Akiskal HS, Hantouche EG, Allilaire JF (2003). Bipolar II with and without cyclothymic temperament: 'dark' and 'sunny' expressions of soft bipolarity. J Affect Disord 73:49-57.
4. Ansseau M, Demyttenaere K, Heyrman J, Migeotte A, Leyman S, Mignon A (2009). Objective: remission of depression in primary care. The Oreon Study. Eur Neuropsychopharmacol 19:169-176.
5. Benazzi F (2003). Frequency of bipolar spectrum in 111 private practice depression outpatients. Eur Arch Psychiatry Clin Neurosci 253:203-208.
6. Benazzi F (2004). Factor structure of recalled DSM-IV hypomanic symptoms of bipolar II disorder. Compr Psychiatry 45:441-446.
7. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ (2004). The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry 161:1264-1269.
8. Cassano GB, Benvenuti A, Miniati M, Calugi S, Mula M, Maj M, et al. (2009a). The factor structure of lifetime depressive spectrum in patients with unipolar depression. J Affect Disord 115:87-99.
9. Cassano GB, Mula M, Rucci P, Miniati M, Frank E, Kupfer DJ, et al. (2009b). The structure of lifetime manic-hypomanic spectrum. J Affect Disord 112:59-70.
10. Dombrovski AY, Blakesley-Ball RE, Mulsant BH, Mazumdar S, Houck PR, Szanto K, Reynolds CF Jr (2006). Speed of improvement in sleep disturbance and anxiety compared to core mood symptoms during acute treatment of depression in old age. Am J Geriatr Psychiatry 14: 550-555.
11. Dombrovski AY, Mulsant BH, Houck PR, Mazumdar S, Lenze EJ, Andreescu C, et al. (2007). Residual symptoms and recurrence during maintenance treatment of late-life depression. J Affect Disord 103:77-82.
12. Endicott J, Nee J, Harrison W, Blumenthal R (1993). Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29:321-326.
13. Fagiolini A, Dell'Osso L, Pini S, Armani A, Bouanani S, Rucci P, et al. (1999). Validity and reliability of a new instrument for assessing mood symptomatology: the structured clinical interview for mood spectrum (SCI-MOODS). Int J Methods Psychiatr Res 8:71-82.
14. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA (1994). Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151:1295-1299.
15. Fava GA, Fabbri S, Sonino N (2002). Residual symptoms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry 26:1019-1027. (Pubitemid 35256092)
16. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S (2004). Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 161:1872-1876.
17. Fava GA, Ruini C, Belaise C (2007). The concept of recovery in major depression. Psychol Med 37:307-317.
18. Frank E, Shear MK, Rucci P, Cyranowski JM, Endicott J, Fagiolini A, et al. (2000). Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression. Am J Psychiatry 157: 1101-1107.
19. Frank E, Cassano GB, Rucci P, Fagiolini A, Maggi L, Kraemer HC, et al. (2008). Addressing the challenger of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression. Clin Trials 5:253-261.
20. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
21. Hantouche EG, Angst J, Akiskal HS (2003). Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum. J Affect Disord 73:39-47.
22. Judd LL, Akiskal HS (2003). The prevalence and disability of bipolar spectrum disorders in the US population: reanalysis of the ECA database taking into account subthreshold cases. J Affect Disord 73:123-131.
23. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. (1998). Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50:97-108.
24. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al. (2000). Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 57:375-380.
25. Judd LL, Schettler PJ, Akiskal HS (2002). The prevalence, clinical relevance and public health significance of subthreshold depressions. Psychiatr Clin North Am 25:685-698.
26. Keitner GI, Ryan CE, Solomon DA (2006). Realistic expectations and a disease management model for depressed patients with persistent symptoms. J Clin Psychiatry 67:1412-1421.
27. Kennedy N, Paykel ES (2004). Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 80:135-144.
28. Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P (2007). Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord 9:25-37.
29. Klerman GL, Weissmann MM (1987). Interpersonal psychotherapy (IPT) and drugs in the treatment of depression. Pharmacopsychiatry 20:3-7.
30. Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, et al. (1992). Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49:769-773.
31. Lewinsohn PM, Zinbarg R, Seeley JR, Lewinsohn M, Sack WM (1997). Lifetime comorbidity among anxiety disorders an between anxiety disorders and other mental disorders in adolescents. J Anxiety Disord 11:377-394.
32. Lewinsohn PM, Holm-Denoma JM, Small JW, Seely JR, Joiner TE Jr (2008). Separation anxiety disorder in childhood as a risk factor for future mental illness. J Am Acad Child Adolesc Psychiatry 47:548-555.
33. Lowe B, Spitzer RL, Williams JBW, Mussell M, Schellberg D, Kroenke K (2008). Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 30:191-199.
34. McIntyre RS, O'Donovan C (2004). The human cost of not achieving full remission in depression. Can J Psychiatry 49:10S-16S.
35. Mendlewicz J (2008). Towards achieving remission in the treatment of depression. Dialogues Clin Neurosci 10:371-375.
36. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RMA (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 10:144-152.
37. Moller HJ (2008). Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. World J Biol Psychiatry 9:102-114.
38. Mundt JC, Marks IM, Shear MK, Greist JH (2002). The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry 180:461-464.
39. Murphy JM, Monson RR, Olivier DC, Sobol AM, Leighton AH (1987). Affective disorders and mortality. A general population study. Arch Gen Psychiatry 44:473-480.
40. Papakostas GI, Petersen T, Mahal J, Mischoulon D, Nierenberg AA, Fava M (2004). Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 26:13-17.
41. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995). Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25:1171-1180.
42. Pintor L, Gastó C, Navarro V, Torres X, Fañanas L (2003). Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Dis 73:237-244.
43. Prien RF, Kupfer DJ (1986). Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 143:18-23.
44. Rucci P, Rossi A, Mauri M, Maina G, Pieraccini F, Pallanti S, et al. (2007). Validity and reliability of Quality of Life, Enjoyment and Satisfaction Questionnaire, Short Form. Epidemiol Psichiatr Soc 16:82-89.
45. Rucci P, Miniati M, Oppo A, Mula M, Calugi S, Frank E, et al. (2009). The structure of lifetime panic-agoraphobic spectrum. J Psychiatr Res 43:366-379.
46. Schechter D, Endicott J, Nee J (2007). Quality of life of 'normal' controls: association with lifetime history of mental illness. Psychiatry Res 30:45-54.
47. Shear MK, Frank E, Rucci P, Fagiolini DA, Grochocinski VJ, Houck P, et al. (2001). Panic agoraphobic spectrum: reliability and validity of assessment instruments. J Psychiatr Res 35:59-66.
48. Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, et al. (2004). Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry 61: 669-680.
49. Trivedi MH, Hollander E, Nutt D, Blier P (2008). Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 69:246-258.
50. Van Londen L, Molenaar RP, Goekoop JG, Zwinderman AH, Rooijmans HG (1998). Three to 5 year prospective follow-up of outcome in major depression. Psychol Med 28:731-735.
51. Verhagen M, Van der Meij A, Franke B, Vollebergh W, De Graaf R, Buitelaar J, Janzing JG (2008). Familiarity of major depressive disorder and gender differences in comorbidity. Acta Psychiatr Scand 118:130-138.
52. Weissman MM, Klerman GL, Paykel ES, Prusoff B, Hanson B (1974). Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry 30:771-778.
53. Weissman MM, Klerman GL, Prusoff BA, Sholomskas D, Padian N (1981). Depressed outpatients: results one year after treatment with drugs and/or interpersonal therapy. Arch Gen Psychiatry 38:51-55.
54. Wijeratne C, Manicavasagar V (2003). Separation anxiety in the elderly. J Anxiety Disord 17:695-702.
55. Zimmerman M, Posternak M, Friedman M, Chelminski I (2005). A standardized clinical outcome rating scale for depression for use in clinical practice. Depress Anxiety 22:36-40.
56. Zimmerman M, Posternak MA, Chelminski I (2007). Heterogeneity among depressed outpatients considered to be in remission. Compr Psychiatry 48:113-117.